AMRC three-lens brief
Evidence-based stock research on AMRC. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -4.02% yesterday. · Negative free cash flow last quarterly (-$445.51M).
- Moved -4.02% yesterday.
- Outperforming SPY by 28.4pp over 30 days.
- Analyst mean target $39.10 — 47% above current (10 analysts).
- Negative free cash flow last quarterly (-$445.51M).
- Reported earnings on 2026-11-09.
AMRC closed at $26.51 (-4.02%) as of 2026-11-12. Market cap: $1.41B. P/E (trailing) 50.0. Price is above the 50-day MA and above the 200-day MA. Positives: outperforming SPY by 28.4pp over 30 days.; analyst mean target $39.10 — 47% above current (10 analysts).. Concerns: moved -4.02% yesterday.; negative free cash flow last quarterly (-$445.51M).. Last quarter: Revenue $580.32M, net income $31.88M, free cash flow -$445.51M.
Why three lenses on AMRC, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMRC across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AMRC" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMRC brief"></iframe>